Ipca Laboratories Limited (NSE:IPCALAB)

Ipca Laboratories Revenue

Ipca Laboratories had revenue of 23.09B INR in the quarter ending June 30, 2025, with 10.33% growth. This brings the company's revenue in the last twelve months to 91.57B, up 11.50% year-over-year. In the fiscal year ending March 31, 2025, Ipca Laboratories had annual revenue of 89.41B with 16.03% growth.

• Revenue (ttm): 91.57B
• Revenue Growth: +11.50%
• P/S Ratio: 3.78
• Revenue / Employee: 5.46M
• Employees: 16,778
• Market Cap: 346.53B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	89.41B	12.35B	16.03%
Mar 31, 2024	77.06B	14.58B	23.33%
Mar 31, 2023	62.48B	4.18B	7.16%
Mar 31, 2022	58.31B	4.10B	7.56%
Mar 31, 2021	54.21B	7.71B	16.58%